BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Allos Therapeutics, Inc. Reports Interim Response and Safety Data from Pivotal Phase 2 PROPEL Trial

  May 15, 2008

   · 

  10 min read
• Virionyx Release: Novel Microparticle Offers Immunological Breakthrough Against a Range of Infectious Diseases and Potentially Some Cancers

  May 15, 2008

   · 

  1 min read
• Pharm Country

  Pluristem Therapeutics to be Featured on RedChip’s Real Radio(TM) Show Broadcast

  May 15, 2008

   · 

  1 min read
• Drug Development

  Cerenis Therapeutics, Inc. Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease

  May 15, 2008

   · 

  2 min read
• Business

  Leerink Swann and Company Names Stephen Weiss as Senior Managing Director, Head of Institutional Equities; John Sullivan as Director of Research

  May 15, 2008

   · 

  1 min read
• FDA

  St. Jude Medical Announces FDA Clearance and European CE Mark Approval for Tools That Help Place Leads in Challenging Heart Anatomy

  May 15, 2008

   · 

  6 min read
• Genetown

  AVEO Pharmaceuticals, Inc. to Present at the 2008 Citi Investment Research Global Health Care Conference

  May 15, 2008

   · 

  1 min read
• Pharm Country

  QMed, Inc. Will Discontinue its Operations

  May 15, 2008

   · 

  1 min read
• Business

  SeraCare Life Sciences, Inc. Reports Second Quarter Fiscal Year 2008 Results

  May 15, 2008

   · 

  1 min read
• FDA

  India’s Ranbaxy Laboratories’ Gets FDA Nod for Cyclobenzaprine HCL

  May 15, 2008

   · 

  1 min read